Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Manufacturing
Experts hold line against mass compounding of GLP-1 obesity meds
The recent implosion of Novo’s team-up with telehealth firm Hims & Hers suggests there is still very much a demand for imitation weight loss drugs.
Fraiser Kansteiner
Jun 27, 2025 10:36am
How Lilly is tapping automation, robots and local talent in NC
Jun 26, 2025 8:50am
Lilly, Novo will be pharma sales leaders by 2030, Evaluate says
Jun 23, 2025 9:52am
Lilly fills out lineup of Zepbound doses on self-pay website
Jun 16, 2025 11:48am
Novo's Wegovy secures preferred obesity spot on CVS formulary
May 1, 2025 2:39pm
Eli Lilly CEO critiques Trump trade policies, tariffs
May 1, 2025 1:11pm
